Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6) - Image 1

£111.19

Academic Press Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Name: Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
Brand: Academic Press
Price: 111.19 GBP
Availability: InStock

Biological Science

Price History & Forecast

Last 45 days • 45 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 45 days • 1 price levels

Days at Price

Price Analysis

Most common price: £111 (45 days, 100.0%)

Price range: £111 - £111

Price levels: 1 different prices over 45 days

Description

Product Description Improving the Therapeutic Ratio in Head and Neck Cancer provides a complete review of current approaches to modulating therapeutic sensitivity in head and neck cancer. It presents a broad background of current approaches and by highlighting the potential for clinical translational, introduces a roadmap for how to move promising preclinical findings into the clinic. The book discusses topics such as immunotherapy and molecularly targeted therapies in head and neck cancer, PI3k/mTOR pathway, autophagy inhibition to sensitize HNC to radiation and chemotherapy, TAM and Eph/Ephrin family proteins and metabolic reprogramming to modulate therapeutic sensitivity. Additionally, it details approaches to improve the response to immunotherapy, and Chk1/2 inhibition in radiation and cetuximab resistance. This book is a valuable source to head and neck cancer researchers and advanced students, and to those studying specific approaches in other model systems and disease sites. Review Presents novel approaches to improve therapeutic ratio for patients with head and neck cancer About the Author Benjamin Bonavida, PhD, has been involved in the field of immunology and cancer biology for several decades and has published extensively in the fields of cancer resistance, chemotherapy, immunotherapy, and various molecular approaches to circumvent the resistance of the cancer cells using sensitizing agents. Accordingly, he was the first to publish a book on tumor sensitization in 2008. More recently, Dr. Bonavida is the Series Editor of 3 series published by Elsevier/Academic Press (“Cancer Sensitizing Agents for Chemotherapy, “Breaking Cancer Resistance to Therapeutic Antibodies, and “Breaking Tolerance to Anti-Cancer Immunotherapy) and several books have been published and many are in development. He has published extensively in the field of NK biology and cytotoxicity in the past, and many of these publications were in collaboration with the co-editor Dr. Anahid Jewett. Dr. Kimple completed his MD, PhD in Pharmacology, and residency in Radiation Oncology at the University of North Carolina. He is an Associate Professor of Human Oncology at the University of Wisconsin School of Medicine and Public Health where he is a member of the Multidisciplinary Head and Neck Program and the Wisconsin Head and Neck Cancer SPORE Grant. He runs a translational research lab focused on understanding the molecular basis of therapeutic resistance in head and neck cancer.

Product Specifications

Brand: Academic Press
Format: Hardcover
ASIN: 012817868X
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Biological Science
Domain: Amazon UK
Release Date: 09 October 2019
Listed Since: 07 June 2019

Barcode

No barcode data available

Academic Press Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Successes and Challenges of NK Immunotherapy: Breaking Tolerance to Cancer Resistance

Prognostic and Therapeutic Applications of RKIP in Cancer

Springer - Resistance to Immunotherapeutic Antibodies in Cancer

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Targeting Cell Survival Pathways to Enhance Response to Chemotherapy (Volume 3) (Cancer Sensitizing Agents for Chemotherapy, Volume 3)

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy)

Molecular Determinants of Head and Neck Cancer (Current Cancer Research)

Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy (Volume 18) (Cancer Sensitizing Agents for Chemotherapy, Volume 18)

Head and Neck Cancer: Multimodality Management

Nitric Oxide and Cancer: Pathogenesis and Therapy

Role of Nutraceuticals in Cancer Chemosensitization (Volume 2) (Cancer Sensitizing Agents for Chemotherapy, Volume 2)

Cancer Vaccines as Immunotherapy of Cancer

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Springer - Novel Immunotherapeutic Approaches to Cancer Treatment

Demos Medical Head and Neck Cancers: Evidence-Based Treatment

Humana - Increasing the Therapeutic Ratio of Radiotherapy

Autophagy in Immune Response: Impact on Cancer Immunotherapy (Volume 1) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 1)

Horizons in Cancer Research: Volume 71

Advances in Cancer Treatment: From Systemic Chemotherapy to Targeted Therapy

Humana PI3K-mTOR in Cancer and Cancer Therapy Book

Advances in Cancer Research: Volume 142

Humana Combination Cancer Therapy: Modulators and Potentiators

Advances in Cancer Research: Volume 130